Zepbound (Tirzepatide) Shortage Update: What Patients Need to Know Right Now

The bottom line: Zepbound (tirzepatide) has experienced significant supply turbulence since its 2023 FDA approval, driven by overwhelming demand, manufacturing scale-up challenges, and competition for production capacity. While the FDA removed tirzepatide from its official drug shortage list in late 2024, real-world availability remains inconsistent — and many patients are still struggling to find their dose at a nearby pharmacy. Here's everything you need to know to protect your treatment.

---

A Quick Look at Zepbound's Shortage History

When Eli Lilly's Zepbound hit the market in December 2023, it was already carrying enormous expectations. Its active ingredient — tirzepatide — had already proven itself as Mounjaro for type 2 diabetes, and patients and physicians alike were eager to use the newly approved weight management version.

The demand was immediate. And the supply? It couldn't keep up.

Tirzepatide was officially listed on the FDA's drug shortage database, which triggered a period during which compounding pharmacies were legally permitted to produce copies of the medication. For patients, that meant some access — but also a landscape full of confusion about which products were legitimate, which doses were available, and which pharmacies actually had stock.

Then, in late 2024, the FDA declared that the tirzepatide shortage had been resolved and removed it from the shortage list. Eli Lilly ramped up manufacturing significantly, and on paper, supply caught up with demand.

But here's what "resolved" doesn't always mean in practice: pharmacies don't stock every dose uniformly, distribution across regions is uneven, and demand for GLP-1 and GIP/GLP-1 medications continues to grow rapidly. Patients on certain doses — particularly higher maintenance doses like 10 mg, 12.5 mg, and 15 mg — may still find themselves calling pharmacy after pharmacy with no luck.

---

Why Zepbound Is Uniquely Challenging to Keep in Stock

Understanding why this happens can help you plan better and stress less. A few factors make Zepbound particularly prone to availability gaps:

1. Demand Grew Faster Than Anyone Anticipated

GLP-1 and GIP/GLP-1 medications have become some of the most prescribed drugs in the United States in a remarkably short period of time. Tirzepatide, in clinical trials, showed weight loss results — up to 20–22% of body weight in some participants — that the medical community hadn't seen from a non-surgical intervention before. When results like that get out, prescriptions skyrocket.

2. Manufacturing Injectable Medications Is Genuinely Complex

Zepbound isn't a pill. It's a subcutaneous injectable that requires sterile manufacturing conditions, specialized equipment, and meticulous quality control. You can't just flip a switch and double production overnight. Eli Lilly has invested billions in expanding capacity, but biologics manufacturing takes time — often years — to scale responsibly.

3. Multiple Doses, Multiple Demand Patterns

Zepbound is prescribed across six doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Patients start low and titrate up. That means demand for starter doses (2.5 mg and 5 mg) tends to spike with new prescriptions, while demand for higher doses builds over time as existing patients progress. This creates unpredictable, shifting demand that's hard for both manufacturers and pharmacies to anticipate.

4. Regional Distribution Gaps

Even when national supply looks healthy, your local CVS or Walgreens might be out. Pharmaceutical distribution doesn't flow evenly across every zip code. Smaller towns, rural areas, and certain regions may consistently see lower stock than major metro areas.

5. Compounding Confusion and Transition Chaos

When the FDA resolved the shortage and cracked down on compounding pharmacies producing tirzepatide copies, many patients who had been using compounded versions needed to transition to brand-name Zepbound. That transition created a new surge in demand for authorized product — which briefly stressed supply chains again.

---

What the FDA Says Now

As of the time of writing, the FDA does not list tirzepatide (Zepbound/Mounjaro) on its official drug shortage database. The agency considers the shortage resolved.

However, the FDA's shortage list reflects national supply at the manufacturer level — not what's sitting on the shelf at your corner pharmacy. It's entirely possible for a drug to be "off the shortage list" while individual patients still struggle to fill their prescriptions consistently.

The FDA has also taken a firm stance on compounding: now that the shortage is officially resolved, compounding pharmacies are no longer permitted to produce tirzepatide copies under the shortage exemption. If you encounter a compounding pharmacy still selling "tirzepatide," be cautious — that product may not be legal or subject to the same safety standards as FDA-approved Zepbound.

For the most current status, you can check the FDA drug shortage database directly.

---

What to Do If You Can't Find Zepbound in Stock

If you're hitting walls at your usual pharmacy, here's a practical game plan:

Don't Skip Doses Without Talking to Your Doctor First

Missing doses of Zepbound isn't just inconvenient — it can affect your progress. Your appetite regulation and metabolic response are built up gradually, and interruptions can set you back. Before you skip a dose or reduce your frequency, call your prescriber. They may have guidance specific to your situation.

Call Ahead — But Be Strategic About It

Calling individual pharmacies is tedious and often fruitless. If you do call, ask specifically: "Do you have Zepbound [your exact dose] in stock right now?" Don't just ask if they "carry" it — many pharmacies list it in their system but don't have your specific pen on the shelf.

Ask About Mounjaro

If you're using Zepbound for weight management but also have type 2 diabetes, your doctor may be able to prescribe Mounjaro — the same molecule (tirzepatide) — which is FDA-approved for diabetes. Availability can differ between the two branded versions depending on your area and insurer. Talk to your prescriber about whether this makes sense for you.

Consider Manufacturer Resources

Eli Lilly offers patient support programs, and their website sometimes includes pharmacy locator tools or savings resources. If you haven't explored Lilly's patient assistance programs, it's worth a look — especially if cost is also a factor alongside availability.

Expand Your Search Radius

It sounds obvious, but many patients only check one or two pharmacies. Stock can vary significantly between a Walmart and a Costco just a few miles apart. Independent pharmacies sometimes carry stock that chain pharmacies have run out of. The more locations you check, the better your odds.

how to find Zepbound in stock near you

---

Working With Your Doctor During a Shortage

Your prescriber is your most important partner here. If Zepbound is consistently hard to find in your area, have an honest conversation about your options.

Questions worth asking:

• Is there a different dose that might be easier to source right now?
• Should we consider a medication pause versus an unplanned gap?
• Is Wegovy (semaglutide) a reasonable alternative for me?
• Can you send my prescription to a different pharmacy chain that may have better stock?
• Are there any clinical trials or manufacturer programs I qualify for?

Your doctor may also be able to provide samples during a gap, or help you navigate prior authorization if switching medications temporarily requires insurance approval.

alternatives to Zepbound

---

Why Zepbound Can Still Be Hard to Track Down

Even with the shortage technically resolved, locating Zepbound in stock near you can feel like a part-time job. There are real, structural reasons this is still happening.

why is Zepbound so hard to find

The short version: demand for GIP/GLP-1 medications is growing faster than the healthcare system's distribution infrastructure was designed to handle. New patients are starting therapy every day, existing patients are titrating to higher doses, and pharmacies are ordering conservatively to avoid overstocking an expensive product. The result is a perpetual "just in time" supply situation that leaves little room for error.

---

When Will Zepbound Availability Fully Stabilize?

Eli Lilly has made enormous investments in manufacturing expansion, and the trajectory is genuinely positive. The FDA's removal of tirzepatide from the shortage list reflects real progress in supply capacity.

That said, calling a firm "fully stabilized" date is difficult — and anyone who gives you an exact timeline is guessing. What's more accurate to say is:

• National supply is substantially better than it was in 2023 or early 2024.
• Regional and dose-specific gaps will likely persist through the near term.
• Demand growth will continue to test supply chains, particularly if new indications (Zepbound is being studied for additional uses including heart failure and sleep apnea) gain FDA approval and expand the patient population.

The best strategy isn't to wait for the problem to fully solve itself — it's to be proactive about finding your specific dose before you run out.

---

How FindUrMeds Helps When You Can't Find Zepbound

At FindUrMeds, we built our service specifically for moments like this.

Instead of you spending hours on hold with pharmacies across town, we do the legwork. We contact our network of 15,000+ pharmacies — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — and find your specific dose of Zepbound in stock at a location near you.

Here's how it works:

1. You tell us what you need — medication, dose, and your location.
2. We contact pharmacies on your behalf.
3. Within 24–48 hours, we point you to a pharmacy that has your prescription in stock.

We work with patients across all 50 states, and we have a 92% success rate — even for medications that are genuinely difficult to find. Over 200 healthcare providers trust us to help their patients navigate exactly these kinds of availability challenges.

You shouldn't have to choose between your health and a scavenger hunt.

---

Frequently Asked Questions

Is Zepbound still on the FDA shortage list?

As of late 2024, the FDA removed tirzepatide (the active ingredient in both Zepbound and Mounjaro) from its official drug shortage database, indicating the manufacturer-level shortage has been resolved. However, individual pharmacy availability can still be inconsistent depending on your location and dose. Check the FDA's shortage database for the most current status.

Can I still get compounded tirzepatide now that the shortage is resolved?

No — now that the FDA has resolved the tirzepatide shortage, compounding pharmacies are no longer permitted to produce copies of the medication under the shortage exemption. Using unapproved compounded tirzepatide now carries legal and safety risks. Stick with FDA-approved Zepbound from authorized pharmacies.

What if my pharmacy is out of my specific Zepbound dose?

Don't assume you're out of options. Availability varies widely between pharmacy chains and locations. Ask your doctor whether a neighboring dose is clinically appropriate as a temporary bridge, expand your pharmacy search radius, and consider using FindUrMeds to check across 15,000+ locations without having to call each one yourself.

Is Mounjaro the same as Zepbound? Can I switch?

Yes — both Mounjaro and Zepbound contain tirzepatide, the same active molecule. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management. Whether switching is appropriate depends on your diagnosis, insurance coverage, and prescriber's judgment. Talk to your doctor before making any changes.

---

Need help finding Zepbound in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Zepbound Near You →

---

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →